that point-of-care and factor concentrate-based
coagulation algorithms result in reduced:
• need for allogeneic blood products 10-16
• mortality 10,12
• incidence of acute kidney injury 13,14
• costs 10,11,17
• re-exploration rate 13 and
• length of stay. 11
These benefits have been demonstrated in
major trauma, 12,17 cardiac surgery, 10,11,13,14,17
paediatric surgery, 16 and post-partum
haemorrhage. 15
The case therefore is clear. We are to introduce
point-of-care and factor concentrate-based
coagulation algorithms in the management of
bleeding and haemostasis. However, creating
such algorithms is not sufficient. We need to
implement them and provide training in
interdisciplinary situations, and monitor
algorithm compliance to ensure that the
patients benefit from the most advanced
bleeding treatment concepts.
5
HHE 2018 | hospitalhealthcare.com
Early monitoring of coagulation
defects at the bedside is key for
a successful specific treatment
References
1 Ranucci M et al. Major
bleeding, transfusions, and
anemia: the deadly triad of
cardiac surgery. Ann Thoracic
Surg 2013;96(2):478–85.
2 Frith D et al. Definition and
drivers of acute traumatic
coagulopathy: clinical and
experimental investigations.
J Thromb Haemost
2010;8(9):1919–25.
3 Rossaint R et al. The European
guideline on management
of major bleeding and
coagulopathy following trauma:
fourth edition. Crit Care 2016,
20(1):100.
4 Shapiro MB et al. Damage
control: collective review. J
Trauma 2000;49(5):969–78.
5 Mannucci PM. Treatment of
von Willebrand’s Disease. N Engl
J Med 2004; 351(7):683–94.
6 Collins PW et al. Fibrin-based
clot formation as an early and
rapid biomarker for progression
of postpartum hemorrhage: a
prospective study. Blood 2014;
124(11):1727–36.
7 Collins PW et al.
Viscoelastometric-guided
early fibrinogen concentrate
replacement during postpartum
haemorrhage: OBS2, a
double-blind randomized
controlled trial. Br J Anaesth
2017;119(3):411–21.
8 Dirkmann D et al. Early
thromboelastometric variables
reliably predict maximum clot
firmness in patients undergoing
cardiac surgery: a step towards
earlier decision making. Acta
Anaesthesiologica Scandinavica
2013; 57(5):594–603.
9 Ganter MT, Hofer
CK.Coagulation monitoring:
Current techniques and clinical
use of viscoelastic point-of-care
coagulation devices. Anesth
analg 2008; 106(5):1366–75.
10 Weber CF et al. Point-of-
care testing: A prospective,
randomized clinical trial of
efficacy in coagulopathic cardiac
surgery patients. Anesthesiology
2012; 117(3):531–47.
11 Pearse BL et al. Protocol
guided bleeding management
improves cardiac surgery
patient outcomes. Vox Sang
2015;109(3):267–79.
12 Stein P et al. Change of
transfusion and treatment
paradigm in major trauma
patients. Anaesthesia
2017;72(11):1317–26.
13 Deppe AC et al. Point-of-
care thromboelastography/
thromboelastometry-based
coagulation management in
cardiac surgery: a meta-analysis
of 8332 patients. J Surg Res
2016;203(2):424–33.
14 Serraino GF, Murphy GJ.
Routine use of viscoelastic
blood tests for diagnosis and
treatment of coagulopathic
bleeding in cardiac surgery:
updated systematic review and
meta-analysis. Br J Anaesth
2017;118(6):823–33.
15 Mallaiah S et al. Introduction
of an algorithm for ROTEM-
guided fibrinogen concentrate
administration in major obstetric
haemorrhage. Anaesthesia
2015;70(2):166–75.
16 Haas T et al. Higher fibrinogen
concentrations for reduction
of transfusion requirements
during major paediatric surgery:
A prospective randomised
controlled trial. Br J Anaesthes
2015;115(2):234–43.
17 Whiting P et al. Viscoelastic
point-of-care testing to
assist with the diagnosis,
management and monitoring
of haemostasis: a systematic
review and cost-effectiveness
analysis. Health Tech Assess
2015;19(58):1–228.